Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis-Reference-Cited by-同舟云学术

Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis

Published:2012-09 Issue:3 Volume:62 Page:472-487
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Briganti Alberto,Wiegel Thomas,Joniau Steven,Cozzarini Cesare,Bianchi Marco,Sun Maxine,Tombal Bertrand,Haustermans Karin,Budiharto Tom,Hinkelbein Wolfgang,Di Muzio Nadia,Karakiewicz Pierre I.,Montorsi Francesco,Van Poppel Hein

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients;Karakiewicz;Urology,2005

2. Pathologic findings at radical prostatectomy: risk factors for failure and death;Swanson;Urol Oncol,2007

3. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911);Bolla;Lancet,2005

4. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial;Thompson;JAMA,2006

5. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial;Thompson;J Urol,2009

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomy;Prostate International;2023-09

2. Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence;Irish Journal of Medical Science (1971 -);2023-04-25

3. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022;European Urology;2023-03

4. Mask R-CNN assisted 2.5D object detection pipeline of 68Ga-PSMA-11 PET/CT-positive metastatic pelvic lymph node after radical prostatectomy from solely CT imaging;Scientific Reports;2023-01-30

5. Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation;Radiotherapy and Oncology;2022-10